MTOR and squamous cell carcinoma of penis: Similarly, PSCC cases had a trend for a lower percentage of cases with positive p-mTOR (Ser2448) cytoplasmic (13/23; 56% vs. 12/15; 80%) and nuclear (7/23; 30% vs. 8/15; 53%) immunoexpression in comparison to NPE cases though this was found to not be statistically significant (p=0.1755 and p=0.1903 respectively).